医薬品添加剤市場：タイプ、剤形、機能別-2024-2030年の世界予測

医薬品添加剤市場規模は、2023年に86億2,000万米ドルと推定され、2024年には92億2,000万米ドルに達し、CAGR 7.62%で2030年には144億2,000万米ドルに達すると予測されています。

医薬品添加剤は、製造工程の改善、安定性の向上、薬剤の生物学的利用能の確保、最終製品の投与や投薬の容易化など、様々な目的で医薬品に添加されます。賦形剤は基本的に不活性成分であり、有効成分の製剤化および送達を全般的にサポートします。医薬品添加剤市場は、世界人口の増加と慢性疾患による医薬品需要の増加が主な要因となっています。また、製剤化技術の進歩や新規賦形剤の開発も市場の成長に寄与しています。さらに、ジェネリック医薬品分野の拡大や軽度の健康問題に対するセルフメディケーションの動向は、賦形剤市場に強い推進力を与えています。しかし、承認プロセスに時間がかかる厳しい規制要件は、新しい賦形剤のイントロダクションを妨げる可能性があり、高度な賦形剤の開発と製造に関連する高コストが市場成長の妨げとなっています。多機能賦形剤や共加工賦形剤へのシフト、バイオベース賦形剤開発のための進行中の進歩や研究活動は、製品性能や生産効率の向上などの利点を提供し、市場プレーヤーに大きなチャンスを開いています。

タイプ有機賦形剤の潜在的需要と利用

無機賦形剤は有機物由来ではない物質であり、様々な機能を果たすために医薬製剤に含まれます。これらの賦形剤には炭酸カルシウムが含まれ、充填剤や希釈剤として、また医薬品の錠剤のカルシウム源として広く使用されています。炭酸カルシウムは、高純度で毒性がなく、費用対効果が高いことから好まれています。第二リン酸カルシウムや第三リン酸カルシウムを含むリン酸カルシウム賦形剤は、圧縮性と流動性に優れ、打錠作業に理想的であることから利用されています。硫酸カルシウムは、錠剤の機械的強度を向上させるための錠剤賦形剤および共加工賦形剤として医薬品に使用されています。亜ハロゲン酸塩、特に塩化ナトリウムは等張溶液を作り、経口薬の安定剤や矯味矯臭剤として使用されます。医薬製剤では、マグネシウムや酸化亜鉛などの金属酸化物は、pH調整剤、着色剤、栄養補助剤として機能します。有機賦形剤とは、医薬品製剤に含まれる有機（炭素系）由来の物質を指します。炭水化物は、経口固形製剤の充填剤、結合剤、安定剤です。微結晶セルロースを含むセルロース誘導体は賦形剤市場で多用されており、結合性、崩壊性、フィルム形成性が評価されています。デンプンおよびその誘導体は、錠剤の崩壊剤、結合剤、充填剤として使用され、医薬品の形状に良好な機械的特性を与えています。スクロースなどの糖類は、甘味料や水溶性薬剤の結晶基剤としてシロップ剤やトローチ剤によく使用されます。

脂肪アルコールは非イオン性界面活性剤であり、外用剤のエモリエント剤として原薬の皮膚浸透を助ける。グリセリンは、経口剤、外用剤、非経口剤を含む様々な医薬製剤において、溶媒、保湿剤、防腐剤として使用されます。マグネシウムなどのミネラル・ステアリン酸塩は、錠剤製造における潤滑剤として主に使用され、錠剤圧搾機の効率的な稼働を保証しています。錠剤製剤では、ポリメチルメタクリレートを含むアクリルポリマーなどの石油化学製品は、フィルムコーティング、結合剤、徐放性マトリックス形成剤として機能します。プロピレングリコールなどのグリコール類は、原薬の溶媒として汎用性が高く、注射剤、外用剤、シロップ剤など多くの医薬品製剤に使用されています。パラフィンのような鉱物性炭化水素は、その潤滑特性からカプセル剤に、また様々な軟膏やクリームの基剤として使用されます。さらに、ポビドン類は錠剤の結合剤、液剤の可溶化剤、頬部用の生体接着剤として使用されます。ゼラチンやコラーゲンなどのタンパク質は、薬剤カプセルの形成やフィルム形成剤として使用されます。その生分解性と人体への適合性により、特定の医薬品用途には欠かせないものとなっています。

製剤：ドラッグデリバリーの利便性から経口製剤の需要が大きいです。

経口製剤は経口経路で投与される剤形であり、最も便利で一般的に使用されるドラッグデリバリー方法の一つです。このセグメントには、医薬品有効成分の安定性、放出、バイオアベイラビリティ（API）を補助するために設計された様々な賦形剤が含まれます。ハードゼラチンカプセルは、1種類以上の原薬と賦形剤が小さな殻の中に封入された固形剤です。硬質ゼラチンカプセルはまた、投与量の正確さや優れた安定性などの利点を提供します。ソフトゼラチンカプセル（ソフトゲル）は、カプセルと同様の経口剤形であるが、ゼラチンベースの殻が液体充填物を取り囲んでいます。嚥下しやすく、難溶性原薬のバイオアベイラビリティを高めることができるため、好まれています。液体製剤には、経口投与される溶液、懸濁液、乳剤が含まれます。これらの製剤における賦形剤の選択は、安定性、嗜好性、原薬の適切な吸収を確保するために極めて重要です。錠剤は一般的な経口剤形であり、錠剤用の賦形剤市場は依然として堅調です。錠剤製造に使用される成分は、化合物を結合させ、崩壊を助け、安定性を高める。非経口剤は、体内組織に直接投与することを目的とした無菌製剤です。局所製剤は皮膚や粘膜に塗布し、有効成分を作用部位や全身循環に直接送達します。

機能：コーティング剤は薬剤に物理的・化学的保護を与えます。

結合剤は、錠剤の強度と完全性を向上させ、粉末粒子を凝集させ、一緒に保持するために錠剤に使用される接着材料です。コーティング剤は、不快な味をマスキングし、薬剤を物理的・化学的に保護し、薬剤の放出を制御するために、様々な剤形の外面に塗布されます。着色剤は、製品の識別を容易にし、審美性を高めるために医薬品に添加されます。崩壊剤は、投与後に消化管内で錠剤の崩壊を促進し、医薬品有効成分の迅速な放出と吸収を可能にする重要な賦形剤です。その機能性により、錠剤が流体環境に入ると、より小さな破片に効率的に崩壊します。乳化剤は、非混和性液体間の界面における表面張力を低下させることにより、エマルションの形成および安定化を補助します。乳化剤は、クリーム、軟膏、懸濁液などの製剤に不可欠であり、系内での薬物の均一な分布を促進します。充填剤と希釈剤は、錠剤やカプセルの嵩を増加させる不活性添加剤であり、製造が実用的で取り扱いが容易になります。香味剤と甘味剤は、経口薬の嗜好性を改善し、原薬やその他の賦形剤による不快な風味や臭いをマスキングします。滑沢剤は、成分の凝集を防ぎ、圧縮時に錠剤が金型からスムーズに排出されるようにするために配合剤に添加されます。保存剤は、医薬品中の微生物の増殖を抑え、保存期間を延ばし、使用中の安全性を確保します。懸濁剤や粘稠剤は、液体製剤中の不溶性粒子の均一な分散状態を維持し、液体製剤の流動特性（粘度）を調整します。これにより、毎回の投与で均一な投薬量が確保され、診療の安定性が向上します。

地域別の洞察

南北アメリカ地域は、厳しい規制状況、先進ヘルスケアシステム、強力な知的財産フレームワークにより、賦形剤に対する高い需要を示しているため、市場情勢において重要な位置を占めています。医薬品イノベーションの重要な情勢を背景に、この地域の国々は医薬品製剤用の高度で新規な賦形剤に強く注目しています。欧州、中東・アフリカを含むEMEA地域は、多様な市場特性を示しています。一方、中東とアフリカの市場は急成長しており、医薬品製造インフラと規制への投資が増加しています。EU市場は、複雑な医薬品や高度なドラッグデリバリーシステムに対応する最先端の医薬品添加剤に対する高いニーズを示しています。さらに、EUのバイオ医薬品とバイオシミラーへの投資は、これらの分野における新規賦形剤への需要の高まりによって補完されています。アジア太平洋地域の国々は、大規模な患者プール、増加するヘルスケア支出、政府の支援策により、大きな成長を遂げている医薬品添加剤分野の主要プレーヤーです。同地域では、高機能賦形剤の研究開発を継続的に行い、輸入品への依存度を下げることで、技術革新に注力しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医薬品添加剤市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、医薬品添加剤市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.医薬品添加剤市場の市場規模および予測は？

2.医薬品添加剤市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.医薬品添加剤市場の技術動向と規制枠組みは？

4.医薬品添加剤市場における主要ベンダーの市場シェアは？

5.医薬品添加剤市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんやその他の慢性疾患、感染症の発生率が上昇
    • 医薬品業界の成長とジェネリック医薬品および希少疾病用医薬品の大きな需要
    • 多機能賦形剤の製造に重点を置く
  • 抑制要因
    • 高度な賦形剤の製造に伴う高コスト
  • 機会
    • 賦形剤のナノテクノロジーにおける技術的進歩
    • さまざまな特性を持つ賦形剤の継続的な研究開発（バイオベース）
  • 課題
    • 規制の厳格化と添加剤の適合性に関する問題の増加
• 市場セグメンテーション分析
  • タイプ：有機添加剤の潜在的需要と利用
  • 製剤：ドラッグデリバリーの利便性から経口製剤の需要が高い
  • 機能：コーティング剤は薬剤を物理的、化学的に保護します
• 市場動向分析
  • 南北アメリカにおける医薬品添加剤の需要を促進するために医薬品製造を増やすための多額の投資
  • アジア太平洋における医薬品の輸出を促進するための政府の支援策
  • 医薬品業界の繁栄と、EMEA地域での医薬品製造の現地化への注目の高まり
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 医薬品添加剤市場：タイプ別

• 無機
• オーガニック

第7章 医薬品添加剤市場処方別

• 経口製剤
• 非経口製剤
• 局所用製剤

第8章 医薬品添加剤市場：機能別

• バインダー
• コーティング剤
• 着色剤
• 崩壊剤
• 乳化剤
• 充填剤と希釈剤
• 香料・甘味料
• 潤滑剤と滑剤
• 防腐剤
• 懸濁剤および粘性剤

第9章 南北アメリカの医薬品添加剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の医薬品添加剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの医薬品添加剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ロケット社が湿気対策の新技術を発表
  • クラリアント、バルセロナのCPHIでAPIの安定性と溶解性を向上させる新しい添加剤シリーズを発表
  • BASFとIFFがバーチャル製薬アシスタントプラットフォームZoomLabで提携
  • ルブリゾール、受賞歴のあるアピソレックス賦形剤をウェルトン・ファーマにライセンス供与し、新たながん治療薬を開発
  • イングレディオン、高付加価値医薬品原料への戦略的投資拡大を発表
  • DFE Pharma、Lactohale 400の発売により吸入ポートフォリオを拡大
  • エボニックは米国政府と提携し、米国にmRNAベースの治療薬用の新しい脂質生産施設を建設するために2億2,000万米ドルを投資します。
  • ルーブリゾールがアピソレックス技術を発表
  • ユニバーソリューションズ、アッシュランドとの新たな販売契約を通じて医薬品ポートフォリオを拡大
  • アゼリス、ロケットとの提携拡大でインドにおける医薬品事業を強化
  • ロケット社、クレスト・セルロース社の完全買収により植物由来賦形剤ポートフォリオの世界展開を拡大

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
• FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 81. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 82. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 83. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 84. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 85. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 86. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 87. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 88. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 89. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 90. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 91. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 92. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 93. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 94. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 95. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 96. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 97. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 98. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 99. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 100. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 101. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 104. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 105. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 106. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 107. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 108. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 109. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 110. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 111. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 112. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 113. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 114. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 115. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 116. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 117. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 118. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 119. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 120. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 121. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 124. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 125. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 126. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 127. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 128. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 129. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 130. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 131. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 132. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 133. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 134. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 135. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 136. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 137. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 138. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 139. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 140. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 141. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 142. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 143. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 144. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 145. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 146. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 147. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 148. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 149. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 150. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 151. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 152. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 153. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 154. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 155. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 156. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 157. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 160. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 161. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 162. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 163. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 164. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 165. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 166. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 167. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 168. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 169. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 170. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 171. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 172. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 173. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 174. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 175. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 178. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 179. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 180. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 181. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 182. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 183. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 184. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 185. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 186. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 187. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 188. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 189. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 190. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 191. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 192. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 193. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 196. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 197. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 198. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 199. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 200. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 201. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 202. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 203. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 204. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 205. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 206. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 207. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 208. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 209. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 210. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 211. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 212. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 213. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 214. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 215. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 216. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 217. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 218. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 219. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 220. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 221. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 222. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 223. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 224. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 225. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 226. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 227. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 228. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 229. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 230. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 231. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 232. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 233. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 234. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 235. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 236. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 237. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 238. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 239. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 240. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 241. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 242. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 243. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 244. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 245. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 246. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 247. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 248. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 249. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 250. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 251. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 252. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 253. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 254. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 255. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 256. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 257. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 258. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 259. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 260. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 261. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 262. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 263. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 264. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 265. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 266. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 267. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 268. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 269. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 270. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 271. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 272. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 273. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 274. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 275. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 276. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 277. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 278. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 279. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 280. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 281. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 282. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 283. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 284. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 285. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 286. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 287. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 288. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 289. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 290. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 291. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 292. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 293. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 294. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 295. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 296. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 297. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 298. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 299. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 300. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 301. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 302. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 303. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 304. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 305. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 306. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 307. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 308. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 309. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 310. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 311. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 312. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
• TABLE 313. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 314. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 315. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
• TABLE 316. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
• TABLE 317. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 318. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 319. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
• TABLE 320. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
• TABLE 321. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
• TABLE 322. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
• TABLE 323. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 324. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 325. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
• TABLE 326. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
• TABLE 327. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
• TABLE 328. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
• TABLE 329. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
• TABLE 330. MALAYSIA P

[194 Pages Report] The Pharmaceutical Excipient Market size was estimated at USD 8.62 billion in 2023 and expected to reach USD 9.22 billion in 2024, at a CAGR 7.62% to reach USD 14.42 billion by 2030.

Pharmaceutical excipients are added to pharmaceutical products for various purposes, including improving the manufacturing process, enhancing stability, ensuring the bioavailability of the drug, and facilitating the administration and dosing of the final product. Excipients are essentially inactive components that support the overall formulation and delivery of the active ingredient. The market for pharmaceutical excipients is primarily driven by the increasing demand for pharmaceutical products due to the rising global population and chronic diseases. Technological advancements in drug formulation and developing novel excipients also contribute to market growth. Furthermore, the expansion of the generic pharmaceuticals sector and the trend toward self-medication for minor health issues provide a strong impetus for the excipient market. However, stringent regulatory requirements leading to lengthy approval processes can impede the introduction of new excipients, and the high cost associated with developing and producing advanced excipients hamper its market growth. The shift toward multifunctional and co-processed excipients and ongoing advancements and research activities for developing biobased excipients opens significant opportunities for market players, offering benefits such as improved product performance and production efficiency.

Type: Potential demand and utilization of organic excipients

Inorganic excipients are substances not of organic origin and are included in pharmaceutical formulations to serve various functions. These excipients include calcium carbonate, widely used as a filler or diluent, and a source of calcium in pharmaceutical tablets. It is favored for its high purity, non-toxic nature, and cost-effectiveness. Calcium phosphate excipients, including dicalcium phosphate and tricalcium phosphate, are utilized for their excellent compressibility and flow properties, making them ideal for tableting operations. Calcium sulfate is used in pharmaceuticals as a tablet excipient and a co-processed excipient to improve the mechanical strength of tablets. Halites, especially sodium chloride, create isotonic solutions and are used as stabilizers and taste-masking agents in oral medications. In pharmaceutical formulations, metal oxides such as magnesium and zinc oxide function as pH adjusters, colorants, and nutrient supplements. Organic excipients refer to substances of organic (carbon-based) origin that are included in pharmaceutical formulations. Carbohydrates are fillers, binders, and stabilizers in oral solid dose formulations. Cellulose derivatives, including microcrystalline cellulose, are prolific in the excipient market, valued for their binding, disintegrating, and film-forming properties. Starch and its derivatives are used as disintegrants, binders, and fillers in tablets, providing good mechanical properties to pharmaceutical forms. Sugars such as sucrose are often used in syrups and lozenges as sweeteners and crystalline bases for water-soluble drugs.

Fatty alcohols are non-ionic surfactants and emollients in topical formulations, aiding in skin penetration of APIs. Glycerin is used as a solvent, humectant, and preservative in various pharmaceutical preparations, including oral, topical, and parenteral formulations. Mineral stearates such as magnesium are predominantly used as lubricants in tablet manufacture, ensuring the efficient running of tablet presses. In tablet formulations, petrochemicals such as acrylic polymers, including polymethyl methacrylate, serve as film coatings, binders, and sustained-release matrix formers. Glycols such as propylene glycol are versatile solvents for APIs and are used in many pharmaceutical preparations, including injectables, topical formulations, and syrups. Mineral hydrocarbons such as paraffin are used for their lubricating properties in capsules and as bases in various ointments and creams. Furthermore, povidones are used as binders in tablet formulations, as solubilizers in liquids, and as bioadhesives for buccal applications. Proteins such as gelatin and collagen are used to form drug capsules and as film-forming agents. Their biodegradability and compatibility with the human body make them vital for specific pharmaceutical applications.

Formulation: Significant demand for oral formulations owing to its convenient drug delivery

Oral formulations are dosage forms administered through the oral route, one of the most convenient and commonly used drug delivery methods. This segment includes a variety of excipients designed to aid the active pharmaceutical ingredient's stability, release, and bioavailability (API). Hard gelatin capsules are solid dosage forms in which one or more drug substances and excipients are enclosed within a small shell. They also offer advantages such as dose precision and good stability. Soft gelatin capsules (soft gels) are an oral dosage form for medicine similar to capsules; however, they consist of a gelatin-based shell surrounding a liquid fill. They are favored for their ease of swallowing and ability to enhance the bioavailability of poorly soluble APIs. Liquid formulations include solutions, suspensions, and emulsions that are taken orally. The choice of excipients in these formulations is critical to ensure stability, palatability, and proper absorption of the API. Tablets are a popular oral dosage form, and the excipient market for tablets remains robust. The ingredients used in tablet manufacturing bind the compound, aid in disintegration, and enhance stability. Parenteral formulations are sterile preparations intended to be administered directly into the body tissues. Topical formulations are applied to the skin or mucous membranes to deliver active ingredients directly to the site of action or systemic circulation.

Function: Coating agents provide physical and chemical protection for the drug

Binders are adhesive materials used in tablet formulations to agglomerate and hold the powder particles together, enhancing the strength and integrity of the tablet. Coating agents are applied to the exterior of various dosage forms to mask unpleasant tastes, provide physical and chemical protection for the drug, and control the release of the drug substance. Colorants are added to pharmaceuticals to facilitate product identification and enhance aesthetic appeal. Disintegrants are critical excipients that promote the breakup of a tablet in the digestive tract after administration, permitting the rapid release and absorption of the active pharmaceutical ingredient. Their functionality ensures the tablet disintegrates efficiently into smaller fragments when it enters a fluid environment. Emulsifying agents assist in the formation and stabilization of emulsions by reducing surface tension at the interface between the immiscible liquids. They are crucial for formulations such as creams, ointments, and suspension-based systems and facilitate the homogeneous distribution of the drug substance within the system. Fillers and diluents are inert additives that increase a tablet or capsule's bulk volume, making it practical to produce and easy to handle. Flavoring agents and sweeteners improve the palatability of oral medications, masking any unpleasant flavors and odors from the active drug or other excipients. Lubricants are added to formulation blends to prevent ingredients from clumping and to ensure a smooth ejection of the tablet from the die during compression. Preservatives contain the growth of microbes in pharmaceutical products, extending their shelf life and ensuring safety during use. Suspending and viscosity agents help maintain a uniformly dispersed state of insoluble particles in a liquid dosage form and can modulate liquid preparations' flow properties (viscosity). This ensures a uniform dose of medication with each administration and improves the stability of the practice.

Regional Insights

The Americas region has a significant landscape in the pharmaceutical excipient market as countries exhibit a high demand for excipients, directed by stringent regulatory environments, advanced healthcare systems, and strong intellectual property frameworks. Having a significant landscape in pharmaceutical innovation, the countries in the region strongly focus on advanced and novel excipients for drug formulations. The EMEA region, which encompasses Europe, the Middle East, and Africa, shows diverse market characteristics. The stringent regulatory environment in the European Union drives the demand for compliant and high-quality excipients, whereas markets in the Middle East and Africa are burgeoning, with increasing investment in pharmaceutical manufacturing infrastructure and regulation. The EU market demonstrates a high need for cutting-edge pharmaceutical excipients that cater to complex drugs and sophisticated drug delivery systems. Moreover, the EU's investment in biopharmaceuticals and biosimilars is complemented by the growing demand for novel excipients in these areas. Countries in the Asia-Pacific region are key players in the pharmaceutical excipient sector experiencing substantial growth due to a large patient pool, increasing healthcare expenditures, and supportive government initiatives. The region focuses on innovating high-functional excipients with ongoing research and development, reducing its historical reliance on imports.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Excipient Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Excipient Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Aceto Corp., Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L'AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Resonac Holdings Corporation, Roquette Freres S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Excipient Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Inorganic
    • Calcium Carbonate
    • Calcium Phosphate
    • Calcium Sulfate
    • Halites
    • Metal Oxides

• Organic
  • Carbohydrates
    • Cellulose
    • Starch
    • Sugars

• Oleochemicals
  • Fatty Alcohols
  • Glycerin
  • Mineral Stearates

• Petrochemicals
  • Acrylic Polymers
  • Glycols
  • Mineral Hydrocarbons
  • Povidones

• Proteins
• Formulation
  • Oral Formulations
    • Hard Gelatin Capsules
    • Liquid Formulations
    • Soft Gelatin Capsules
    • Tablets

• Parenteral Formulations
• Topical Formulations

• Function
  • Binders
  • Coating Agents
  • Colorants
  • Disintegrants
  • Emulsifying Agents
  • Fillers & Diluents
  • Flavoring Agents & Sweeteners
  • Lubricants & Glidants
  • Preservatives
  • Suspending & Viscosity Agents

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharmaceutical Excipient Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Excipient Market?

3. What are the technology trends and regulatory frameworks in the Pharmaceutical Excipient Market?

4. What is the market share of the leading vendors in the Pharmaceutical Excipient Market?

5. Which modes and strategic moves are suitable for entering the Pharmaceutical Excipient Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
    • 5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
    • 5.1.1.3. Significant emphasis on the production of multifunctional excipients
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of advanced excipient
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in nanotechnology for excipients
    • 5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Potential demand and utilization of organic excipients
  • 5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
  • 5.2.3. Function: Coating agents provide physical and chemical protection for the drug
• 5.3. Market Trend Analysis
  • 5.3.1. Substantial investments to increase drug manufacturing to propel the demand for pharmaceutical excipient in the Americas
  • 5.3.2. Supportive government initiatives to encourage exports of pharmaceutical products in the Asia-Pacific
  • 5.3.3. Flourishing pharmaceutical sector, coupled with a growing focus on localizing drug manufacturing in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Pharmaceutical Excipient Market, by Type

• 6.1. Introduction
• 6.2. Inorganic
• 6.3. Organic

7. Pharmaceutical Excipient Market, by Formulation

• 7.1. Introduction
• 7.2. Oral Formulations
• 7.3. Parenteral Formulations
• 7.4. Topical Formulations

8. Pharmaceutical Excipient Market, by Function

• 8.1. Introduction
• 8.2. Binders
• 8.3. Coating Agents
• 8.4. Colorants
• 8.5. Disintegrants
• 8.6. Emulsifying Agents
• 8.7. Fillers & Diluents
• 8.8. Flavoring Agents & Sweeteners
• 8.9. Lubricants & Glidants
• 8.10. Preservatives
• 8.11. Suspending & Viscosity Agents

9. Americas Pharmaceutical Excipient Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pharmaceutical Excipient Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Excipient Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Roquette Introduces New Advancement in Moisture Protection
  • 12.3.2. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
  • 12.3.3. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
  • 12.3.4. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
  • 12.3.5. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
  • 12.3.6. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
  • 12.3.7. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
  • 12.3.8. Lubrizol Launches Apisolex Technology
  • 12.3.9. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
  • 12.3.10. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
  • 12.3.11. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio